300
Participants
Start Date
August 31, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
May 30, 2029
Standard of Care
To use the patients age, tumor size, grade, and lymph node status and any genomic tests (i.e. OncotypeDx, MammaPrint etc to determine risk of recurrence,
Mount Sinai Hospital, New York
OTHER
Precise Dx, Inc.
INDUSTRY